NCT01830491View on ClinicalTrials.gov

Comparison of Effect & Safety of Clopidogrel Napadisilate With Clopidogrel Bisulfate in Coronary Artery Disease Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

162

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

August 31, 2009

Study Completion Date

December 31, 2009

Conditions
Coronary Artery Disease (CAD)
Interventions
DRUG

Clopidogrel

DRUG

aspirin 100mg

Sponsors
All Listed Sponsors
lead

Hanmi Pharmaceutical Company Limited

INDUSTRY

NCT01830491 - Comparison of Effect & Safety of Clopidogrel Napadisilate With Clopidogrel Bisulfate in Coronary Artery Disease Patients | Biotech Hunter | Biotech Hunter